Your session is about to expire
← Back to Search
Transcutaneous spinal cord stimulation for Dysautonomia
Study Summary
This trial is looking at whether or not transcutaneous spinal cord stimulation can help improve autonomic nervous system function in people with spinal cord injury.
- Dysautonomia
- Autonomic Dysreflexia
- Neurogenic Orthostatic Hypotension
- Spinal Cord Injury
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the present enrollment number for this trial?
"Affirmative. Clinicaltrials.gov data confirms that this trial is actively enrolling 10 patients from a single site; the project was initially posted on February 17th 2022, with its most recent update occurring on September 29th 2022."
What type of individuals is this investigation particularly targeting?
"This clinical study is seeking 10 patients aged 18-30 with a spinal cord injury which occurred within the last year. In addition, participants should have an American Spinal Injury Association Impairment Scale score of A and a neurological level of injury between T1-T6 as defined by International Standards for Neurological Classification of Spinal Cord Injury criteria."
Is there room for new participants in this clinical experiment?
"This research is recruiting participants, as per information provided on clinicaltrials.gov. The project was inaugurated on February 17th 2022 and the last update occurred September 29th 2022."
Are elderly individuals being offered enrollment in this trial?
"Enrolment in this experiment is restricted to those between 18 and 30 years old. There are 46 trials recruiting minors and 395 for seniors."
Share this study with friends
Copy Link
Messenger